Back to Search
SAMUEL BEENKEN, MD
MD
Pain Medicine Physician
NPI: 1801830815Individual
Specialties, Licenses & Credentials
Research & Publications (16)
Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
PMID 12724640·Ann Surg·2003
8-other
Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53.
PMID 11323501·Ann Surg·2001
3-trial
Extent of surgery for intermediate-risk well-differentiated thyroid cancer.
PMID 10737579·Am J Surg·2000
8-other
Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator.
PMID 15328178·Clin Cancer Res·2004
3-trial
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers.
PMID 14580682·Cancer Lett·2003
7-preclinical
Conformationally defined retinoic acid analogues. 5. Large-scale synthesis and mammary cancer chemopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-dihydro-1'(2'H)-naphthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid (9cUAB30).
PMID 12904083·J Med Chem·2003
7-preclinical
Risk biomarker assessment for breast cancer progression: replication precision of nuclear morphometry.
PMID 12775917·Anal Cell Pathol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5510 HIGHWAY 280, SUITE 215
BIRMINGHAM, AL 35242 - Phone
- (205) 624-4325
Quick Facts
- NPI
- 1801830815
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 16
Are you this provider?
Claim Your Profile